• Pharma Targeting Celebrates 10 years of Connecting People Intelligently

    Feb 22, 2023, 10:07 AM by
    Pharma Targeting, the bespoke research house exclusively working with pharma and biotech service providers, is celebrating its 10-year anniversary in 2023. Launched as a small custom research agency - part of The Targeting Group - the company has grown exponentially in the past decade, with global offices now across the UK, Europe, Argentina and India, and employing nearly 300 people with a backbone of world class life science experts, business strategists and marketing consultants, along with 200 PhD analysts.
    Full story
  • BRIM Biotechnology strengthens leadership team in preparation for transformational year ahead

    Feb 22, 2023, 10:06 AM by
    RIM’s new Board of Directors elects Andrew Lin as the new Chairman of the Board and appoints Dr. Wen-Chyi Shyu as the new CEO
    Full story
  • Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona

    Feb 22, 2023, 10:05 AM by
    Phastar Take Lead on Making Sense of Visual Data Analytics at ACDM23 Barcelona Specialist biometrics CRO are key sponsor and presenter at industry event to support continuous professional development in clinical data management
    Full story
  • Gut Microbiome Implicated In Endometriosis

    Feb 22, 2023, 01:00 AM by User Not Found
    Bio-IT World | The gut microbiome has for the first time been linked to a causal role in endometriosis. Up to now, efforts to investigate the contributing factors have been focused primarily on genetic changes or epigenetic disorders and yet understanding of the underlying pathology remains largely a mystery.
    Full story
  • Follow the Money: Waters Acquires Wyatt to Build Bioanalytical Characterization Business, NIAID Establishes Immunology Data Analysis Institute, More

    Feb 21, 2023, 01:00 AM by User Not Found
    Bio-IT World | Funding for a proprietary AI-driven 3D structure engine for RNA drug discovery, unique binary assembly technology to deliver accurate, gene-length DNA in a benchtop instrument, a national institute that develops artificial intelligence systems to identify and assist young children with speech and language processing challenges, and more.
    Full story
  • Emory Healthcare Engages Linus Health on Initiative to Expand Early Detection of Alzheimer’s Disease and Other Dementias

    Feb 17, 2023, 10:15 AM by
    Goizueta Institute @Emory Brain Health and The Seavey Clinic Collaborating on Use of Digital Cognitive Assessments in Primary Care
    Full story
  • VisualDx Partners with American Medical Women's Academy to Offer Diagnostic Support Technology to Women in Medicine

    Feb 17, 2023, 10:15 AM by
    To support greater equity in healthcare, VisualDx just partnered with the American Medical Women’s Academy (AMWA) to grant all members access to its clinical decision support tool for diagnostic and treatment decisions. As you may know, this collaboration follows the company’s partnerships with the Gates Foundation, HHS, state of Vermont, and ACEP to enhance patient care and outcomes.
    Full story
  • Exploring the Changing Approach to Drug Safety

    Feb 17, 2023, 01:00 AM by User Not Found
    Bio-IT World | Pharmacovigilance plays a critical role in drug safety. Pharmaceutical companies monitor newly licensed drugs, evaluate previously unreported adverse reactions, and balance drug effectiveness. We are evolving from manual pharmacovigilance to an era of precision pharmacovigilance, where a personalized approach to drug safety helps maximize the reach of new drugs and minimize adverse events.
    Full story
  • Proscia Builds Momentum In Life Sciences Market Led By Customer And Product Growth

    Feb 16, 2023, 09:43 AM by
    14 of the top 20 pharmaceutical companies now rely on Concentriq to accelerate R&D
    Full story
  • Natural Language Processing Designs Original Proteins From Scratch

    Feb 16, 2023, 01:00 AM by User Not Found
    Bio-IT World | Using a natural language processing program developed by Salesforce Research, scientists have engineered artificial enzymes that look and fold just like natural proteins and function just as well. The artificial intelligence tool, called ProGen, allows information from the evolutionary record of multiple protein families to generate new enzymes that could prove therapeutically useful.
    Full story
  • Equiva Partners with Infiniti Mobile to Advance Health Equity Via Newly Unveiled Affordable Connectivity-Focused Program

    Feb 15, 2023, 09:13 AM by
    Equiva Health, a digital patient engagement and health relationship management solution provider, is announcing its partnership with ISP provider Infiniti Mobile to launch its new ACP Connect Program. Equiva and Infiniti Mobile are working together to create a framework to help hospitals, nursing homes, and other healthcare organizations enroll patients in the Affordable Connectivity Program (ACP), and to help these organizations engage digitally with individuals for targeted health initiatives. Through this partnership and offering, Equiva aims to further narrow the digital divide in healthcare and improve healthcare access for at-risk populations by connecting more eligible patients with ACP’s discounted broadband service and devices—allowing those patients to take advantage of digital health solutions they haven’t previously had affordable access to.
    Full story
  • Big Sky Care Connect Selects Rhapsody Interoperability Suite from Lyniate

    Feb 14, 2023, 10:53 AM by
    Full story
  • MIB Agents Awards $200,000 in Grants to Colorado-based Researchers Studying Pediatric Osteosarcoma

    Feb 14, 2023, 10:47 AM by
    MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, recently presented $100,000 each to Michael Leibowitz, MD, PhD from the University of Colorado Cancer Center and Dr. Daniel Regan, DVM, PhD, DACVP from the Flint Animal Cancer Center at Colorado State University, totaling $200,000 in research funds to move rare bone cancer research forward. Christina Ip-Toma, MIB Agents’ Director of Scientific Programs, presented the award to Dr. Leibowitz on February 8 and Dr. Regan on February 9.
    Full story
  • New Zinc-Finger Technology Makes For Faster, Better Genetic Editing

    Feb 14, 2023, 01:00 AM by User Not Found
    Bio-IT World | CRISPR-based approaches that rely on the enzyme Cas9 to cut DNA at precise locations has been the darling of genetics research over the past few years. The revolutionary gene-editing system can also produce a lot of off-target activity. And when delivered via adeno-associated virus vectors, Cas9 occupies so much space that little room is left for any other therapeutic cargo that might be needed.
    Full story
  • Verana Health Announces Release of Qdata Module for Non-Muscle Invasive Bladder Cancer RWE Analysis

    Feb 13, 2023, 11:04 AM by
    Second Urology Qdata Module to Provide Real-World Evidence from more than 50,000 De-identified Patients in the American Urological Association’s (AUA) Quality Registry (AQUA)
    Full story
  • Biopharma PEG Supplies Multi-arm PEG Derivatives Crosslinked Into Hydrogels

    Feb 13, 2023, 10:50 AM by
    Full story
  • Huateng Pharma Supplies Tetrahydrocurcumin With Large Scale

    Feb 10, 2023, 09:45 AM by
    About Huateng Pharma Huateng Pharma is a global provider in contract development and manufacturing for pharmaceutical intermediates. With our focus on operational excellence, and the integration of manufacturing operations with EHS, quality assurance, quality control, regulatory, supply chain management and project management, we can manufacture, scale-up and supply high-quality intermediates and APIs from our China facility. We have established a 5000 square meters R&D center and have our own manufacturing site covering 34,000 square meters. Contact us Hunan Huateng Pharmaceutical Co. Ltd. Address: Lugu Business Plaza E1, Yuelu District, Changsha City, Hunan Province, China Manufacturing Base: Tongguan Kiln, Wangcheng district, Changsha, Hunan, China Email: sales@huatengusa.com Website: https://us.huatengsci.com Zip code: 410205 Telephone: +86 731 89916275 Fax: +86 0731-82251112-818
    Full story
  • OncoDxRx Emerges from Stealth Mode with World-First PGA Technology

    Feb 10, 2023, 09:44 AM by
    OncoDxRx's innovative technology, for the first time, brings two worlds together - from gene expression to drug efficacy.
    Full story
  • Bioassays Have An Integration Problem: Collaboration Will Be Key To Making Them FAIR

    Feb 10, 2023, 01:00 AM by User Not Found
    Bio-IT World | Whilst life science companies have come to recognize data as their greatest asset, it is also their greatest challenge. Much of data is siloed in different formats and locations, making it difficult to discover, query, and share—rendering data essentially unusable. FAIR data must be rolled out across the entire industry if companies want to accelerate R&D and enable scientific queries to be answered more rapidly.
    Full story
  • BSI LIFE SCIENCES AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS

    Feb 9, 2023, 10:59 AM by
    BSI Life Sciences specializes in state-of-the-art software for life sciences (CTMS, eTMF and more) and Ledger Run, Inc., an innovative technology company focused on optimizing clinical operations in the areas of site budgeting and payments, announced their partnership today. Through the partnership, BSI Life Sciences’ Clinical Trial Management software BSI CTMS™ and Ledger Run’s unique ClinRun™ platform will streamline and enhance clinical operation budgeting and payment processes with an intelligent approach and seamless integration.
    Full story